āagmanLoginNot investment advice. Data and computed figures, for information only.
Nephrocare Health Services Ltd
₹611.65
−₹5.50 (−0.89%)
NSE · 15 Oct 2026, close
Market Cap
₹6,198 Cr
CMP
₹611.65
52-wk High / Low
₹782 / 446
P/E
72.8
P/B
5.6
Book Value
₹111.0
Div Yield
0.00%
ROCE
15.0%
ROE
8.8%
Face Value
₹2
D/E
0.07
Price+29.8% over Max
āagman read
Computed by āagmanPiotroski F-Score
5
/ 9
5 of 9 F-score tests passed
Graham Number
₹138
√(22.5 × EPS × book value per share)
ROIC
8.9%
vs 11.2% sector median
Cash flow to profit
3.03
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+22
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
8.8%
ROE × earnings retention ratio
ROE stability
6.7
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII −1.16DII +0.41
Latest quarter vs the previous one
Cash-accrual divergence
−12.7%
of assets
Low = accruals track cash flow
Strengths
+Price trades above its 200-day moving average (1.0x)
Watch-outs
−Latest ROCE of 15% trails the sector median of 17%
Peer comparison
| Name | P/E | Mar Cap ₹ Cr | ROCE % | ROE % |
|---|
Quarterly results
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 197 | 219 | 228 | 246 | 260 | 266 | 282 |
| Expenses | 153 | 168 | 180 | 182 | 199 | 215 | 221 |
| Operating Profit | 44 | 51 | 48 | 64 | 61 | 51 | 60 |
| OPM % | 22.3% | 23.3% | 21.1% | 26.0% | 23.5% | 19.2% | 21.3% |
| Other Income | 5 | 4 | 7 | 4 | 3 | 12 | 7 |
| Interest | 5 | 6 | 6 | 45 | 6 | 3 | 2 |
| Depreciation | 18 | 19 | 20 | 23 | 22 | 26 | 25 |
| Profit before tax | 26 | 30 | 29 | −1 | 36 | 33 | 41 |
| Net Profit | 20 | 25 | 24 | −9 | 32 | 30 | 32 |
| EPS (₹) | 96.50 | 119.30 | 13.10 | −5.24 | 3.21 | 3.03 | 3.19 |
Profit & Loss
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 286 | 318 | 437 | 566 | 756 | 999 | 1,053 |
| Expenses | 248 | 302 | 389 | 465 | 589 | 774 | 817 |
| Operating Profit | 37 | 16 | 49 | 101 | 167 | 225 | 236 |
| OPM % | 12.9% | 5.0% | 11.2% | 17.8% | 22.1% | 22.5% | 22.4% |
| Other Income | 5 | 10 | 6 | 8 | 14 | 23 | 26 |
| Interest | 7 | 10 | 16 | 20 | 21 | 60 | 56 |
| Depreciation | 34 | 42 | 47 | 56 | 72 | 91 | 96 |
| Profit before tax | 1 | −27 | −9 | 33 | 87 | 97 | 110 |
| Net Profit | 1 | −21 | −12 | 35 | 67 | 77 | 85 |
| EPS (₹) | 3.40 | −106.93 | −58.69 | 169.82 | 321.87 | 7.66 | 4.19 |
Balance Sheet
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 20 | — |
| Reserves | 245 | 391 | 384 | 409 | 579 | 1,096 | — |
| Borrowings | 140 | 119 | 200 | 271 | 261 | 80 | — |
| Other Liabilities | 42 | 59 | 81 | 124 | 153 | 271 | — |
| Total Liabilities | 428 | 571 | 666 | 806 | 994 | 1,467 | — |
| Fixed Assets | 192 | 205 | 239 | 356 | 396 | 517 | — |
| CWIP | 2 | 43 | 34 | 1 | 6 | 6 | — |
| Investments | 0 | 0 | 0 | 0 | 51 | 178 | — |
| Other Assets | 234 | 322 | 393 | 449 | 542 | 767 | — |
| Total Assets | 428 | 571 | 666 | 806 | 994 | 1,467 | — |
Cash Flows
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | 32 | 14 | 11 | 72 | 135 | 233 |
| Cash from Investing Activity | −62 | −130 | −76 | −52 | −125 | −392 |
| Cash from Financing Activity | 36 | 121 | 60 | 27 | 54 | 157 |
| Net Cash Flow | 5 | 6 | −4 | 47 | 65 | −2 |
Ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| ROCE % | — | −4.0 | 1.0 | 8.0 | 14.0 | 15.0 |
| ROE % | — | — | — | — | — | 8.8 |
| EPS (₹) | 3.40 | −106.93 | −58.69 | 169.82 | 321.87 | 7.66 |
| Book Value (₹) | — | — | — | — | — | 111.0 |
| Face Value (₹) | — | — | — | — | — | 2 |
| P/E | — | — | — | — | — | 72.8 |
| Div Yield % | — | — | — | — | — | 0.00 |
| NPM % | 0.3 | −6.4 | −2.7 | 6.1 | 8.7 | 7.5 |
| OPM % | 13.0 | 5.0 | 11.0 | 18.0 | 22.0 | 23.0 |
| D/E | 0.57 | 0.30 | 0.52 | 0.66 | 0.45 | 0.07 |
| P/B | — | — | — | — | — | 5.6 |
Growth
Compounded sales growth
5 years+28.0%
3 years+32.0%
TTM+32.0%
Compounded profit growth
5 years+162.0%
3 years+103.0%
TTM+12.0%
Return on equity
5 years6.0%
3 years10.0%
Last year9.0%
Documents
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Closure of Trading WindowAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAnnouncement under Regulation 30 (LODR)-Credit RatingCorporate actions
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman